Sullivan Timothy Eugene

Related Filers (2)

Other (7)

144
Monday, 2/12/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/29/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/22/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/16/2024
Filing for proposed sale of securities under Rule 144
144
Thursday, 11/30/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/3/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 6/5/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (26)

4
Tuesday, 2/13/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/31/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/23/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/17/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/1/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/6/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/6/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/3/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/20/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/1/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/9/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/11/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/1/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/12/2020
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/3/2019
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/12/2019
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/21/2018
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/8/2017
Apellis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Friday, 5/19/2017
G1 Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More